Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988
Authors:
- Daniele NunezDNDaniele Nunez
- Xavier NorelXNXavier Norel
- 1 April 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 123 (2) , 197-205
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Is platelet activating factor (PAF) a mediator of endotoxin shock?European Journal of Pharmacology, 1985
- Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988)Biochemical and Biophysical Research Communications, 1985
- Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by TriazolobenzodiazepinesScience, 1984
- Characteristics of the binding of platelet-activating factor to platelets of different animal speciesEuropean Journal of Pharmacology, 1984
- Effect of 1-alkyl-2-acetyl--glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the ratLife Sciences, 1984
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Effect of structural analogues of PAF‐acether on platelet desensitizationBritish Journal of Haematology, 1983
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)Annals of the New York Academy of Sciences, 1981
- Acetyl Glyceryl Ether Phosphorylcholine: Platelet-Activating FactorInternational Archives of Allergy and Immunology, 1981
- The role of platelet-activating factor in platelet aggregationNature, 1979